GCPj Editorial Board
GCPj's international advisory board are essential in maintaining the journal's
credibility, accuracy and integrity. Members are from a variety of industry sectors,
differing company types and numerous international locations but they share a
commitment to excellence in clinical research.
Board members
|
Cecil Nick
Senior Consultant Worldwide Regulatory Affairs
PAREXEL International
UK |
Dr Charles Pierce
Pharmaceutical Medicine Consultant
US |
Clive Jenkins
Ashdown Clinical Research
UK |
|
Dr Barry Arnold
EU Qualified Person for
Pharmacovigilance
AstraZeneca Int
UK |
Chris Albani
Partner
PRTM
Japan |
Francis P Crawley
Director General
Good Clinical Practice Alliance
Belgium |
|
Dr Frank Wells
Consultant and
Co-Chairman
Working Party of the European Forum for GCP
Belgium |
Gerard Dunne
Managing Director
Beltas CRO
New Zealand |
Gerhard Fortwengel
Director, Head of Quality Systems
Actelion Pharmaceuticals
Switzerland |
|
Dr M Renee Simar
Simar & Associates
US |
Dr Laura Brown
University of Cardiff
UK |
Dr David Dalton
Ixion Consulting
UK |
|
Dr Boris Golubtsov
Director, SQV Clinical Research Services
UK |
Dr William K Sietsema
Vice-President, Clinical and Regulatory Strategic Planning
Kendle
US |
Dr Teri Stokes
Director
GXP International
US |
|
Nigel Crossland
QA Director
Crossland Consultancy Ltd
UK |
Prof Paul Chester
Special Projects Leader
Novo Nordisk
UK |
Dr Stephen DeCherney
President, Clinical Development Services America
Quintiles
US |
|
Professor Richard Sullivan
Chairman
European Cancer Research
Managers Forum
UK |
Dr Jean-Pierre Tassignon
President
Crossover CRI AG
Switzerland |
|
For information on contributing an article to GCPj please contact Jenine Willis
at jenine.willis@informa.com.
|
